{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T12:14:58Z","timestamp":1768911298561,"version":"3.49.0"},"reference-count":215,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T00:00:00Z","timestamp":1637280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioeng. Biotechnol."],"abstract":"<jats:p>During recent years, clustered regularly interspaced short palindromic repeat (CRISPR)\/CRISPR-associated protein 9 (Cas9) technologies have been noticed as a rapidly evolving tool to deliver a possibility for modifying target sequence expression and function. The CRISPR\/Cas9 tool is currently being used to treat a myriad of human disorders, ranging from genetic diseases and infections to cancers. Preliminary reports have shown that CRISPR technology could result in valued consequences for the treatment of Duchenne muscular dystrophy (DMD), cystic fibrosis (CF), \u03b2-thalassemia, Huntington\u2019s diseases (HD), etc. Nonetheless, high rates of off-target effects may hinder its application in clinics. Thereby, recent studies have focused on the finding of the novel strategies to ameliorate these off-target effects and thereby lead to a high rate of fidelity and accuracy in human, animals, prokaryotes, and also plants. Meanwhile, there is clear evidence indicating that the design of the specific sgRNA with high efficiency is of paramount importance. Correspondingly, elucidation of the principal parameters that contributed to determining the sgRNA efficiencies is a prerequisite. Herein, we will deliver an overview regarding the therapeutic application of CRISPR technology to treat human disorders. More importantly, we will discuss the potent influential parameters (e.g., sgRNA structure and feature) implicated in affecting the sgRNA efficacy in CRISPR\/Cas9 technology, with special concentration on human and animal studies.<\/jats:p>","DOI":"10.3389\/fbioe.2021.775309","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T07:13:05Z","timestamp":1637305985000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["RETRACTED: Optimizing sgRNA to Improve CRISPR\/Cas9 Knockout Efficiency: Special Focus on Human and Animal Cell"],"prefix":"10.3389","volume":"9","author":[{"given":"Sadegh","family":"Shojaei Baghini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhanna R.","family":"Gardanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelina Olegovna","family":"Zekiy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navid","family":"Shomali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Foad","family":"Tosan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa","family":"Jarahian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1038\/s41467-018-04252-2","article-title":"The CRISPR Tool Kit for Genome Editing and beyond","volume":"9","author":"Adli","year":"2018","journal-title":"Nat. Commun."},{"key":"B2","doi-asserted-by":"publisher","first-page":"8307","DOI":"10.1021\/acs.jafc.1c02653","article-title":"CRISPR-based Crop Improvements: A Way Forward to Achieve Zero Hunger","volume":"69","author":"Ahmad","year":"2021","journal-title":"J. Agric. Food Chem."},{"key":"B3","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/s0301-0082(99)00032-5","article-title":"Neuroprotective Strategies for Basal Ganglia Degeneration: Parkinson\u2019s and Huntington\u2019s Diseases","volume":"60","author":"Alexi","year":"2000","journal-title":"Prog. Neurobiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/14712598.2020.1725469","article-title":"Clinical Development on the Frontier: Gene Therapy for Duchenne Muscular Dystrophy","volume":"20","author":"Asher","year":"2020","journal-title":"Expert Opin. Biol. Ther."},{"key":"B5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/978-981-15-7142-8_3","article-title":"Delivery Methods, Resources and Design Tools in CRISPR\/Cas","volume-title":"CRISPR Crops","author":"Aslam","year":"2021"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1093\/bioinformatics\/btu048","article-title":"Cas-OFFinder: a Fast and Versatile Algorithm that Searches for Potential Off-Target Sites of Cas9 RNA-Guided Endonucleases","volume":"30","author":"Bae","year":"2014","journal-title":"Bioinformatics"},{"key":"B7","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/nbt.3659","article-title":"Applications of CRISPR Technologies in Research and beyond","volume":"34","author":"Barrangou","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/nature11537","article-title":"In Vivo genome Editing Using a High-Efficiency TALEN System","volume":"491","author":"Bedell","year":"2012","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.canrad.2020.08.048","article-title":"Breast Cancer Radioresistance May Be Overcome by Osteopontin Gene Knocking Out with CRISPR\/Cas9 Technique","volume":"25","author":"Behbahani","year":"2021","journal-title":"Cancer radiotherapie : J. de la Societe francaise de radiotherapie oncologique"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/cells9020308","article-title":"uPAR Knockout Results in a Deep Glycolytic and OXPHOS Reprogramming in Melanoma and Colon Carcinoma Cell Lines","volume":"9","author":"Biagioni","year":"2020","journal-title":"Cells"},{"key":"B11","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1080\/21645698.2015.1137690","article-title":"A Quick Guide to CRISPR sgRNA Design Tools","volume":"6","author":"Brazelton","year":"2015","journal-title":"GM crops & food."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.3390\/ijms20153623","article-title":"Evaluating the Efficiency of gRNAs in CRISPR\/Cas9 Mediated Genome Editing in Poplars","volume":"20","author":"Bruegmann","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"5007","DOI":"10.7150\/jca.46464","article-title":"Graphene Oxide Nanoparticles Induce Apoptosis in Wild-type and CRISPR\/Cas9-IGF\/IGFBP3 Knocked-Out Osteosarcoma Cells","volume":"11","author":"Burnett","year":"2020","journal-title":"J. Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"22312","DOI":"10.1038\/srep22312","article-title":"CRISPR\/cas9, a Novel Genomic Tool to Knock Down microRNA In Vitro and In Vivo","volume":"6","author":"Chang","year":"2016","journal-title":"Scientific Rep."},{"key":"B15","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1021\/acssynbio.6b00343","article-title":"sgRNA Scorer 2.0: a Species-independent Model to Predict CRISPR\/Cas9 Activity","volume":"6","author":"Chari","year":"2017","journal-title":"ACS Synth. Biol."},{"key":"B16","first-page":"520","article-title":"[Rev-erb\u03b2 Knock-out Affectsthe Proliferation, Migration and Invasion Ability of Hepatocellular Carcinoma HepG2 Cell Line In Vitro]. Sichuan da xue xue bao Yi xue ban","volume":"50","author":"Chen","year":"2019","journal-title":"J. Sichuan Univ. Med. Sci. edition"},{"key":"B17","doi-asserted-by":"publisher","first-page":"26582","DOI":"10.1109\/access.2017.2775703","article-title":"Identify Key Sequence Features to Improve CRISPR sgRNA Efficacy","volume":"5","author":"Chen","year":"2017","journal-title":"IEEE Access"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20092271","article-title":"HDAC1,2 Knock-Out and HDACi Induced Cell Apoptosis in Imatinib-Resistant K562 Cells","volume":"20","author":"Chen","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/s41374-018-0056-1","article-title":"Specific Targeting of point Mutations in EGFR L858R-Positive Lung Cancer by CRISPR\/Cas9. Laboratory Investigation","volume":"98","author":"Cheung","year":"2018","journal-title":"a J. Tech. Methods Pathol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s40425-019-0806-7","article-title":"CRISPR-Cas9 Disruption of PD-1 Enhances Activity of Universal EGFRvIII CAR T Cells in a Preclinical Model of Human Glioblastoma","volume":"7","author":"Choi","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"B21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-3-030-42022-2_2","article-title":"Application of Bioinformatics Tools in CRISPR\/Cas","volume-title":"CRISPR\/Cas Genome Editing","author":"Choudhary","year":"2020"},{"key":"B22","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/23808993.2016.1146077","article-title":"Precise Treatment of Cystic Fibrosis\u2013Current Treatments and Perspectives for Using CRISPR","volume":"1","author":"Colemeadow","year":"2016","journal-title":"Expert Rev. Precision Med. Drug Development"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1038\/s41375-018-0065-5","article-title":"An \u201cOff-the-shelf\u201d Fratricide-Resistant CAR-T for the Treatment of T Cell Hematologic Malignancies","volume":"32","author":"Cooper","year":"2018","journal-title":"Leukemia"},{"key":"B24","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.21873\/anticanres.11836","article-title":"Knockdown of EPHA1 Using CRISPR\/CAS9 Suppresses Aggressive Properties of Ovarian Cancer Cells","volume":"37","author":"Cui","year":"2017","journal-title":"Anticancer Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s12539-018-0298-z","article-title":"Review of CRISPR\/Cas9 sgRNA Design Tools","volume":"10","author":"Cui","year":"2018","journal-title":"Interdiscip. Sci. Comput. Life Sci."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21051854","article-title":"Generation of New Isogenic Models of Huntington's Disease Using CRISPR-Cas9 Technology","volume":"21","author":"Dabrowska","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.3390\/ijms21051854","article-title":"Generation of New Isogenic Models of Huntington\u2019s Disease Using CRISPR-Cas9 Technology","volume":"21","author":"Dabrowska","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41592-019-0329-7","article-title":"One-step Generation of Modular CAR-T Cells with AAV-Cpf1","volume":"16","author":"Dai","year":"2019","journal-title":"Nat. Methods"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-015-0846-3","article-title":"Optimizing sgRNA Structure to Improve CRISPR-Cas9 Knockout Efficiency","volume":"16","author":"Dang","year":"2015","journal-title":"Genome Biol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1164\/rccm.200505-840oe","article-title":"Cystic Fibrosis since 1938","volume":"173","author":"Davis","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1128\/jb.01412-07","article-title":"Phage Response to CRISPR-Encoded Resistance in Streptococcus Thermophilus","volume":"190","author":"Deveau","year":"2008","journal-title":"J. Bacteriol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1016\/j.ygeno.2020.04.024","article-title":"Evaluation of Off-Targets Predicted by sgRNA Design Tools","volume":"112","author":"Dhanjal","year":"2020","journal-title":"Genomics"},{"key":"B33","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nbt.3437","article-title":"Optimized sgRNA Design to Maximize Activity and Minimize Off-Target Effects of CRISPR-Cas9","volume":"34","author":"Doench","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/nbt.3026","article-title":"Rational Design of Highly Active sgRNAs for CRISPR-Cas9\u2013Mediated Gene Inactivation","volume":"32","author":"Doench","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"B35","doi-asserted-by":"crossref","DOI":"10.31219\/osf.io\/rvm3z","volume-title":"Genome-wide Association Studies (GWAS) Have Revolutionized Our View of Human Health and Disease Genetics and Offered Novel Gene Therapy Targets","author":"Dowaidar","year":"2021"},{"key":"B36","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/ame2.12091","article-title":"Characterization of two rat models of cystic fibrosis\u2014KO and F508del CFTR\u2014Generated by Crispr\u2010Cas9","volume":"2","author":"Dreano","year":"2019","journal-title":"Anim. models Exp. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jbiotec.2015.11.005","article-title":"Efficient Targeted Mutagenesis in Soybean by TALENs and CRISPR\/Cas9","volume":"217","author":"Du","year":"2016","journal-title":"J. Biotechnol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.omtn.2019.07.009","article-title":"CRISPR-Cas9-Mediated Genome Editing Increases Lifespan and Improves Motor Deficits in a Huntington's Disease Mouse Model","volume":"17","author":"Ekman","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B39","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3389\/fpls.2020.00056","article-title":"Principles, Applications, and Biosafety of Plant Genome Editing Using CRISPR-Cas9","volume":"11","author":"El-Mounadi","year":"2020","journal-title":"Front. Plant Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature21405","article-title":"Targeting a CAR to the TRAC Locus with CRISPR\/Cas9 Enhances Tumour Rejection","volume":"543","author":"Eyquem","year":"2017","journal-title":"Nature"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.123529","article-title":"A Sheep Model of Cystic Fibrosis Generated by CRISPR\/Cas9 Disruption of the CFTR Gene","volume":"3","author":"Fan","year":"2018","journal-title":"JCI insight"},{"key":"B42","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-020-00867-5","article-title":"CRISPR\/CAS9-mediated Knockout of Abi1 Inhibits p185(Bcr-Abl)-Induced Leukemogenesis and Signal Transduction to ERK and PI3K\/Akt Pathways","volume":"13","author":"Faulkner","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/cr.2013.114","article-title":"Efficient Genome Editing in Plants Using a CRISPR\/Cas System","volume":"23","author":"Feng","year":"2013","journal-title":"Cell Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"6677","DOI":"10.21873\/anticanres.14691","article-title":"The Biological Role of the Long Non-coding RNA LINK-A in Ovarian Carcinoma","volume":"40","author":"Filippov-Levy","year":"2020","journal-title":"Anticancer Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/BF00222709","article-title":"Why Are Some Genetic Diseases Common?","volume":"91","author":"Flint","year":"1993","journal-title":"Hum. Genet."},{"key":"B46","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.175.4025.949","article-title":"Gene Therapy for Human Genetic Disease?","volume":"175","author":"Friedmann","year":"1972","journal-title":"Science (New York, NY)"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1534\/genetics.117.202580","article-title":"High-throughput Characterization of Cascade Type IE CRISPR Guide Efficacy Reveals Unexpected PAM Diversity and Target Sequence Preferences","volume":"206","author":"Fu","year":"2017","journal-title":"Genetics"},{"key":"B48","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.tibtech.2013.04.004","article-title":"ZFN, TALEN, and CRISPR\/Cas-based Methods for Genome Engineering","volume":"31","author":"Gaj","year":"2013","journal-title":"Trends Biotechnology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"4254","DOI":"10.1002\/cam4.2257","article-title":"Therapeutic Potential of CRISPR\/Cas9 Gene Editing in Engineered T\u2010cell Therapy","volume":"8","author":"Gao","year":"2019","journal-title":"Cancer Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.omtn.2018.10.016","article-title":"A Single H1 Promoter Can Drive Both Guide RNA and Endonuclease Expression in the CRISPR-Cas9 System","volume":"14","author":"Gao","year":"2019","journal-title":"Mol. Therapy-Nucleic Acids"},{"key":"B51","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/08830185.2019.1677645","article-title":"CRISPR\/Cas: from Adaptive Immune System in Prokaryotes to Therapeutic Weapon against Immune-Related Diseases: CRISPR\/Cas9 Offers a Simple and Inexpensive Method for Disease Modeling, Genetic Screening, and Potentially for Disease Therapy","volume":"39","author":"Garcia-Robledo","year":"2020","journal-title":"Int. Rev. Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.stem.2020.01.019","article-title":"CRISPR-based Adenine Editors Correct Nonsense Mutations in a Cystic Fibrosis Organoid Biobank","volume":"26","author":"Geurts","year":"2020","journal-title":"Cell Stem Cell"},{"key":"B53","article-title":"Improving Efficacy of CAR T Cells through CRISPR\/Cas9 Mediated Knockout of TGFBR2","volume-title":"MOLECULAR THERAPY","author":"Welstead","year":"2018"},{"key":"B54","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.omtn.2018.03.007","article-title":"CRISPR\/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer's Disease","volume":"11","author":"Gy\u00f6rgy","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B55","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.3390\/ijms20153719","article-title":"Strategies to Increase On-Target and Reduce Off-Target Effects of the CRISPR\/Cas9 System in Plants","volume":"20","author":"Hajiahmadi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1186\/s12885-019-5839-2","article-title":"miR-23b and miR-27b Are Oncogenic microRNAs in Breast Cancer: Evidence from a CRISPR\/Cas9 Deletion Study","volume":"19","author":"Hannafon","year":"2019","journal-title":"BMC cancer"},{"key":"B57","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jgg.2017.08.003","article-title":"Self-cleaving Ribozymes Enable the Production of Guide RNAs from Unlimited Choices of Promoters for CRISPR\/Cas9 Mediated Genome Editing","volume":"44","author":"He","year":"2017","journal-title":"J. Genet. genomics= Yi chuan Xue Bao"},{"key":"B58","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1089\/hum.2017.209","article-title":"Vivo Ovarian Cancer Gene Therapy Using CRISPR-Cas9","volume":"29","author":"He","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"B59","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/nmeth.2812","article-title":"Fast CRISPR Target Site Identification","volume":"11","author":"Heigwer","year":"2014","journal-title":"Nat. Methods"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1093\/bioinformatics\/btaa041","article-title":"Generalizable sgRNA Design for Improved CRISPR\/Cas9 Editing Efficiency","volume":"36","author":"Hiranniramol","year":"2020","journal-title":"Bioinformatics"},{"key":"B61","doi-asserted-by":"publisher","first-page":"15644","DOI":"10.1073\/pnas.1313587110","article-title":"Efficient Genome Engineering in Human Pluripotent Stem Cells Using Cas9 from Neisseria Meningitidis","volume":"110","author":"Hou","year":"2013","journal-title":"Proc. Natl. Acad. Sci. United States America"},{"key":"B62","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00005-016-0427-5","article-title":"CRISPR\/Cas9 Immune System as a Tool for Genome Engineering","volume":"65","author":"Hryhorowicz","year":"2017","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"key":"B63","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nbt.2647","article-title":"DNA Targeting Specificity of RNA-Guided Cas9 Nucleases","volume":"31","author":"Hsu","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1089\/hum.2017.234","article-title":"Nucleofection with Plasmid DNA for CRISPR\/Cas9-mediated Inactivation of Programmed Cell Death Protein 1 in CD133-specific CAR T Cells","volume":"30","author":"Hu","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"B65","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1089\/hum.2017.234","article-title":"Nucleofection with Plasmid DNA for CRISPR\/Cas9-Mediated Inactivation of Programmed Cell Death Protein 1 in CD133-specific CAR T Cells","volume":"30","author":"Hu","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/612823","article-title":"Disruption of HPV16-E7 by CRISPR\/Cas System Induces Apoptosis and Growth Inhibition in HPV16 Positive Human Cervical Cancer Cells","volume":"2014","author":"Hu","year":"2014","journal-title":"Biomed. Research International"},{"key":"B67","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s00439-017-1801-z","article-title":"CRISPR\/Cas9-mediated Somatic and Germline Gene Correction to Restore Hemostasis in Hemophilia B Mice","volume":"136","author":"Huai","year":"2017","journal-title":"Hum. Genet."},{"key":"B68","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.trecan.2018.05.006","article-title":"Applications of CRISPR-Cas Enzymes in Cancer Therapeutics and Detection","volume":"4","author":"Huang","year":"2018","journal-title":"Trends Cancer"},{"key":"B69","doi-asserted-by":"publisher","first-page":"5429","DOI":"10.1128\/jb.169.12.5429-5433.1987","article-title":"Nucleotide Sequence of the Iap Gene, Responsible for Alkaline Phosphatase Isozyme Conversion in Escherichia coli, and Identification of the Gene Product","volume":"169","author":"Ishino","year":"1987","journal-title":"J. Bacteriol."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20122888","article-title":"Genome Editing in Agriculture: Technical and Practical Considerations","volume":"20","author":"Jansing","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1002\/1873-3468.12707","article-title":"Chromatin Accessibility and Guide Sequence Secondary Structure Affect CRISPR\u2010Cas9 Gene Editing Efficiency","volume":"591","author":"Jensen","year":"2017","journal-title":"FEBS Lett."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.3892\/ol.2020.11794","article-title":"Knockdown of m6A Methyltransferase METTL3 in Gastric Cancer Cells Results in Suppression of Cell Proliferation","volume":"20","author":"Jiang","year":"2020","journal-title":"Oncol. Lett."},{"key":"B73","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1177\/2472630320922813","article-title":"Core Hairpin Structure of SpCas9 sgRNA Functions in a Sequence-And Spatial Conformation\u2013dependent Manner","volume":"26","author":"Jiang","year":"2021","journal-title":"SLAS TECHNOLOGY: Translating Life Sci. Innovation"},{"key":"B74","doi-asserted-by":"publisher","first-page":"4692","DOI":"10.1158\/0008-5472.can-18-0030","article-title":"CRISPR\/Cas9-Mediated Knockout of DGK Improves Antitumor Activities of Human T Cells","volume":"78","author":"Jung","year":"2018","journal-title":"Cancer Res."},{"key":"B75","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.ymthe.2019.02.014","article-title":"EZH2 Inhibition in Ewing Sarcoma Upregulates G(D2) Expression for Targeting with Gene-Modified T Cells","volume":"27","author":"Kailayangiri","year":"2019","journal-title":"Mol. Ther. : J. Am. Soc. Gene Ther."},{"key":"B76","doi-asserted-by":"publisher","first-page":"11965","DOI":"10.1128\/jvi.01879-14","article-title":"Inactivation of the Human Papillomavirus E6 or E7 Gene in Cervical Carcinoma Cells by Using a Bacterial CRISPR\/Cas RNA-Guided Endonuclease","volume":"88","author":"Kennedy","year":"2014","journal-title":"J. Virol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"851","DOI":"10.2217\/imt-2019-0074","article-title":"Management of Cytokine Release Syndrome: an Update on Emerging Antigen-specific T Cell Engaging Immunotherapies","volume":"11","author":"Khadka","year":"2019","journal-title":"Immunotherapy"},{"key":"B78","doi-asserted-by":"publisher","first-page":"e0245349","DOI":"10.1371\/journal.pone.0245349","article-title":"CRISPR\/Cas9 Mediated Knock-Out of VPREB1 Gene Induces a Cytotoxic Effect in Myeloma Cells","volume":"16","author":"Khaled","year":"2021","journal-title":"PloS one"},{"key":"B79","doi-asserted-by":"publisher","first-page":"73","DOI":"10.22038\/ijbms.2020.50051.11415","article-title":"Genetic Modification of Cystic Fibrosis with \u0394F508 Mutation of CFTR Gene Using the CRISPR System in Peripheral Blood Mononuclear Cells","volume":"24","author":"Khatibi","year":"2021","journal-title":"Iranian J. Basic Med. Sci."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms14406","article-title":"CRISPR\/Cpf1-mediated DNA-free Plant Genome Editing","volume":"8","author":"Kim","year":"2017","journal-title":"Nat. Commun."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1101\/gr.171322.113","article-title":"Highly Efficient RNA-Guided Genome Editing in Human Cells via Delivery of Purified Cas9 Ribonucleoproteins","volume":"24","author":"Kim","year":"2014","journal-title":"Genome Res."},{"key":"B82","doi-asserted-by":"publisher","first-page":"19036","DOI":"10.1270\/jsbbs.19036","article-title":"Parsley Ubiquitin Promoter Displays Higher Activity Than the CaMV 35S Promoter and the chrysanthemum Actin 2 Promoter for Productive, Constitutive, and Durable Expression of a Transgene in Chrysanthemum Morifolium","author":"Kishi-Kaboshi","year":"2019","journal-title":"Breed. Sci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nature16526","article-title":"High-fidelity CRISPR\u2013Cas9 Nucleases with No Detectable Genome-wide Off-Target Effects","volume":"529","author":"Kleinstiver","year":"2016","journal-title":"Nature"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1016\/j.ymthe.2018.05.003","article-title":"Dominant-Negative TGF-\u03b2 Receptor Enhances PSMA-Targeted Human CAR T Cell Proliferation and Augments Prostate Cancer Eradication","volume":"26","author":"Kloss","year":"2018","journal-title":"Mol. Ther."},{"key":"B85","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41587-019-0095-1","article-title":"Increasing the Specificity of CRISPR Systems with Engineered RNA Secondary Structures","volume":"37","author":"Kocak","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"E7301","DOI":"10.1073\/pnas.1705441114","article-title":"In Vivo loss-of-function Screens Identify KPNB1 as a New Druggable Oncogene in Epithelial Ovarian Cancer","volume":"114","author":"Kodama","year":"2017","journal-title":"Proc. Natl. Acad. Sci. United States America"},{"key":"B87","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nbt.2800","article-title":"Genome-wide Recessive Genetic Screening in Mammalian Cells with a Lentiviral CRISPR-Guide RNA Library","volume":"32","author":"Koike-Yusa","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.mib.2017.05.008","article-title":"Diversity, Classification and Evolution of CRISPR-Cas Systems","volume":"37","author":"Koonin","year":"2017","journal-title":"Curr. Opin. Microbiol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"W272","DOI":"10.1093\/nar\/gkw398","article-title":"CHOPCHOP V2: a Web Tool for the Next Generation of CRISPR Genome Engineering","volume":"44","author":"Labun","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"B90","doi-asserted-by":"publisher","first-page":"116742","DOI":"10.1016\/j.lfs.2019.116742","article-title":"R2-8018 Reduces the Proliferation and Migration of Non-small Cell Lung Cancer Cells by Disturbing Transactivation between M3R and EGFR","volume":"234","author":"Lan","year":"2019","journal-title":"Life Sci."},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20225706","article-title":"CRISPR\/Cas9-Mediated Knock-Out of Kras(G12D) Mutated Pancreatic Cancer Cell Lines","volume":"20","author":"Lentsch","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B92","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/bfgp\/elz042","article-title":"Applications and Explorations of CRISPR\/Cas9 in CAR T-Cell Therapy","volume":"19","author":"Li","year":"2020","journal-title":"Brief. Funct. genomics"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-019-0089-y","article-title":"Applications of Genome Editing Technology in the Targeted Therapy of Human Diseases: Mechanisms, Advances and Prospects","volume":"5","author":"Li","year":"2020","journal-title":"Signal. Transduction Targeted Therapy"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep21451","article-title":"Selection of Highly Efficient sgRNAs for CRISPR\/Cas9-based Plant Genome Editing","volume":"6","author":"Liang","year":"2016","journal-title":"Scientific Rep."},{"key":"B95","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1158\/0008-5472.can-18-3374","article-title":"Genome-Wide CRISPR-Cas9 Screen Reveals Selective Vulnerability of ATRX-Mutant Cancers to WEE1 Inhibition","volume":"80","author":"Liang","year":"2020","journal-title":"Cancer Res."},{"key":"B96","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jbiotec.2015.04.024","article-title":"Rapid and Highly Efficient Mammalian Cell Engineering via Cas9 Protein Transfection","volume":"208","author":"Liang","year":"2015","journal-title":"J. Biotechnol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"7473","DOI":"10.1093\/nar\/gku402","article-title":"CRISPR\/Cas9 Systems Have Off-Target Activity with Insertions or Deletions between Target DNA and Guide RNA Sequences","volume":"42","author":"Lin","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"B98","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.1093\/jxb\/ers079","article-title":"The rice ERF Transcription Factor OsERF922 Negatively Regulates Resistance to Magnaporthe Oryzae and Salt Tolerance","volume":"63","author":"Liu","year":"2012","journal-title":"J. Exp. Bot."},{"key":"B99","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3892\/mco.2019.1952","article-title":"Induction of G0\/G1 Phase Arrest and Apoptosis by CRISPR\/Cas9-mediated Knockout of CDK2 in A375 Melanocytes","volume":"12","author":"Liu","year":"2020","journal-title":"Mol. Clin. Oncol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1093\/bioinformatics\/btv423","article-title":"CRISPR-ERA: a Comprehensive Design Tool for CRISPR-Mediated Gene Editing, Repression and Activation","volume":"31","author":"Liu","year":"2015","journal-title":"Bioinformatics"},{"key":"B101","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3389\/fimmu.2019.00456","article-title":"Building Potent Chimeric Antigen Receptor T Cells with CRISPR Genome Editing","volume":"10","author":"Liu","year":"2019","journal-title":"Front. Immunol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep19675","article-title":"Sequence Features Associated with the Cleavage Efficiency of CRISPR\/Cas9 System","volume":"6","author":"Liu","year":"2016","journal-title":"Scientific Rep."},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.cj.2021.05.015","article-title":"Effects of sgRNA Length and Number on Gene Editing Efficiency and Predicted Mutations Generated in rice","author":"Liu","year":"2021","journal-title":"Crop J."},{"key":"B104","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/cr.2016.142","article-title":"CRISPR-Cas9-mediated Multiplex Gene Editing in CAR-T Cells","volume":"27","author":"Liu","year":"2017","journal-title":"Cell Res."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1021\/acssynbio.7b00448","article-title":"High GC Content Cas9-Mediated Genome-Editing and Biosynthetic Gene Cluster Activation in Saccharopolyspora Erythraea","volume":"7","author":"Liu","year":"2018","journal-title":"ACS Synth. Biol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.2147\/cmar.s183859","article-title":"Construction of a GLUT-1 and HIF-1\u03b1 Gene Knockout Cell Model in HEp-2 Cells Using the CRISPR\/Cas9 Technique","volume":"11","author":"Lu","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"B107","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.4142\/jvs.2019.20.e23","article-title":"The Length of Guide RNA and Target DNA Heteroduplex Effects on CRISPR\/Cas9 Mediated Genome Editing Efficiency in Porcine Cells","volume":"20","author":"Lv","year":"2019","journal-title":"J. Vet. Sci."},{"key":"B108","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nrmicro2577","article-title":"Evolution and Classification of the CRISPR\u2013Cas Systems","volume":"9","author":"Makarova","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1902312","DOI":"10.1002\/advs.201902312","article-title":"CRISPR\/Cas Systems in Genome Editing: Methodologies and Tools for sgRNA Design, Off\u2010target Evaluation, and Strategies to Mitigate Off\u2010target Effects","volume":"7","author":"Manghwar","year":"2020","journal-title":"Adv. Sci."},{"key":"B110","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1111\/1759-7714.13676","article-title":"BCAR1 Promotes Proliferation and Cell Growth in Lung Adenocarcinoma via Upregulation of POLR2A","volume":"11","author":"Mao","year":"2020","journal-title":"Thorac. Cancer"},{"key":"B111","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1093\/mp\/sst121","article-title":"Application of the CRISPR\u2013Cas System for Efficient Genome Engineering in Plants","volume":"6","author":"Mao","year":"2013","journal-title":"Mol. Plant"},{"key":"B112","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3389\/fphar.2018.00396","article-title":"Innovative Therapeutic Strategies for Cystic Fibrosis: Moving Forward to CRISPR Technique","volume":"9","author":"Marangi","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"e0228072","DOI":"10.1371\/journal.pone.0228072","article-title":"Challenges Associated with Homologous Directed Repair Using CRISPR-Cas9 and TALEN to Edit the DMD Genetic Mutation in Canine Duchenne Muscular Dystrophy","volume":"15","author":"Mata L\u00f3pez","year":"2020","journal-title":"PloS one"},{"key":"B114","doi-asserted-by":"publisher","first-page":"e0226107","DOI":"10.1371\/journal.pone.0226107","article-title":"Optimizing sgRNA Length to Improve Target Specificity and Efficiency for the GGTA1 Gene Using the CRISPR\/Cas9 Gene Editing System","volume":"14","author":"Matson","year":"2019","journal-title":"PloS one"},{"key":"B115","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/nmeth.4423","article-title":"GUIDES: sgRNA Design for Loss-Of-Function Screens","volume":"14","author":"Meier","year":"2017","journal-title":"Nat. Methods"},{"key":"B116","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s11103-015-0342-x","article-title":"Comparison of CRISPR\/Cas9 Expression Constructs for Efficient Targeted Mutagenesis in rice","volume":"88","author":"Mikami","year":"2015","journal-title":"Plant Mol. Biol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"eaav4324","DOI":"10.1126\/sciadv.aav4324","article-title":"CRISPR-Cas9 Corrects Duchenne Muscular Dystrophy Exon 44 Deletion Mutations in Mice and Human Cells","volume":"5","author":"Min","year":"2019","journal-title":"Sci. Adv."},{"key":"B118","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1111\/febs.13777","article-title":"CRISPR Guide RNA Design for Research Applications","volume":"283","author":"Mohr","year":"2016","journal-title":"FEBS J."},{"key":"B119","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s00239-004-0046-3","article-title":"Intervening Sequences of Regularly Spaced Prokaryotic Repeats Derive from Foreign Genetic Elements","volume":"60","author":"Mojica","year":"2005","journal-title":"J. Mol. Evol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1111\/febs.13766","article-title":"The Discovery of CRISPR in Archaea and Bacteria","volume":"283","author":"Mojica","year":"2016","journal-title":"FEBS J."},{"key":"B121","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.tibtech.2019.01.009","article-title":"Improving CRISPR Genome Editing by Engineering Guide RNAs","volume":"37","author":"Moon","year":"2019","journal-title":"Trends Biotechnology"},{"key":"B122","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/nmeth.3543","article-title":"CRISPRscan: Designing Highly Efficient sgRNAs for CRISPR-Cas9 Targeting In Vivo","volume":"12","author":"Moreno-Mateos","year":"2015","journal-title":"Nat. Methods"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1093\/bioinformatics\/btu743","article-title":"CRISPRdirect: Software for Designing CRISPR\/Cas Guide RNA with Reduced Off-Target Sites","volume":"31","author":"Naito","year":"2015","journal-title":"Bioinformatics"},{"key":"B124","doi-asserted-by":"publisher","first-page":"998","DOI":"10.3390\/cells9040998","article-title":"Effect of CRISPR\/Cas9-Mediated PD-1-Disrupted Primary Human Third-Generation CAR-T Cells Targeting EGFRvIII on In Vitro Human Glioblastoma Cell Growth","volume":"9","author":"Nakazawa","year":"2020","journal-title":"Cells"},{"key":"B125","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2147\/blctt.s230383","article-title":"Knockout of BIRC5 Gene by CRISPR\/Cas9 Induces Apoptosis and Inhibits Cell Proliferation in Leukemic Cell Lines, HL60 and KG1","volume":"9","author":"Narimani","year":"2019","journal-title":"Blood lymphatic Cancer Targets Ther."},{"key":"B126","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1017\/s0021859605005708","article-title":"Crop Losses to Pests","volume":"144","author":"Oerke","year":"2005","journal-title":"J. Agric. Sci."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep32463","article-title":"The Combination of CRISPR\/Cas9 and iPSC Technologies in the Gene Therapy of Human \u03b2-thalassemia in Mice","volume":"6","author":"Ou","year":"2016","journal-title":"Scientific Rep."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms7244","article-title":"Multiplex CRISPR\/Cas9-based Genome Editing for Correction of Dystrophin Mutations that Cause Duchenne Muscular Dystrophy","volume":"6","author":"Ousterout","year":"2015","journal-title":"Nat. Commun."},{"key":"B129","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s40291-019-00392-3","article-title":"Rare Opportunities: CRISPR\/Cas-based Therapy Development for Rare Genetic Diseases","volume":"23","author":"Papasavva","year":"2019","journal-title":"Mol. Diagn. Ther."},{"key":"B130","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.stem.2015.07.001","article-title":"Functional Correction of Large Factor VIII Gene Chromosomal Inversions in Hemophilia A Patient-Derived iPSCs Using CRISPR-Cas9","volume":"17","author":"Park","year":"2015","journal-title":"Cell stem cell"},{"key":"B131","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41593-019-0352-0","article-title":"In Vivo neuronal Gene Editing via CRISPR-Cas9 Amphiphilic Nanocomplexes Alleviates Deficits in Mouse Models of Alzheimer's Disease","volume":"22","author":"Park","year":"2019","journal-title":"Nat. Neurosci."},{"key":"B132","doi-asserted-by":"publisher","first-page":"e497","DOI":"10.3324\/haematol.2018.215178","article-title":"Correction of IVS I-110 (G> A) \u03b2-thalassemia by CRISPR\/Cas-and TALEN-Mediated Disruption of Aberrant Regulatory Elements in Human Hematopoietic Stem and Progenitor Cells","volume":"104","author":"Patsali","year":"2019","journal-title":"Haematologica"},{"key":"B133","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1111\/febs.13586","article-title":"Potential Pitfalls of CRISPR\/Cas9\u2010mediated Genome Editing","volume":"283","author":"Peng","year":"2016","journal-title":"FEBS J."},{"key":"B134","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1099\/mic.0.27437-0","article-title":"CRISPR Elements in Yersinia pestis Acquire New Repeats by Preferential Uptake of Bacteriophage DNA, and Provide Additional Tools for Evolutionary Studies","volume":"151","author":"Pourcel","year":"2005","journal-title":"Microbiology (Reading, England)"},{"key":"B135","doi-asserted-by":"publisher","first-page":"e0119372","DOI":"10.1371\/journal.pone.0119372","article-title":"CRISPR Multitargeter: a Web Tool to Find Common and Unique CRISPR Single Guide RNA Targets in a Set of Similar Sequences","volume":"10","author":"Prykhozhij","year":"2015","journal-title":"PloS one"},{"key":"B136","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.cj.2018.02.005","article-title":"Systematic Identification of Endogenous RNA Polymerase III Promoters for Efficient RNA Guide-Based Genome Editing Technologies in maize","volume":"6","author":"Qi","year":"2018","journal-title":"Crop J."},{"key":"B137","doi-asserted-by":"publisher","first-page":"116586","DOI":"10.1016\/j.lfs.2019.116586","article-title":"CRISPR\/Cas9-mediated Knockout of Lcn2 Effectively Enhanced CDDP-Induced Apoptosis and Reduced Cell Migration Capacity of PC3 Cells","volume":"231","author":"Rahimi","year":"2019","journal-title":"Life Sci."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms5516","article-title":"Expansion of the CRISPR\u2013Cas9 Genome Targeting Space through the Use of H1 Promoter-Expressed Guide RNAs","volume":"5","author":"Ranganathan","year":"2014","journal-title":"Nat. Commun."},{"key":"B139","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1186\/s13287-021-02510-7","article-title":"A Deep Insight into CRISPR\/Cas9 Application in CAR-T Cell-Based Tumor Immunotherapies","volume":"12","author":"Razeghian","year":"2021","journal-title":"Stem Cel. Res. Ther."},{"key":"B140","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3389\/fpls.2019.00612","article-title":"Efficiency Optimization of CRISPR\/Cas9-mediated Targeted Mutagenesis in Grape","volume":"10","author":"Ren","year":"2019","journal-title":"Front. Plant Sci."},{"key":"B141","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1158\/1078-0432.ccr-16-1300","article-title":"Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition","volume":"23","author":"Ren","year":"2017","journal-title":"Clin. Cancer Res. : official J. Am. Assoc. Cancer Res."},{"key":"B142","doi-asserted-by":"publisher","first-page":"17002","DOI":"10.18632\/oncotarget.15218","article-title":"A Versatile System for Rapid Multiplex Genome-Edited CAR T Cell Generation","volume":"8","author":"Ren","year":"2017","journal-title":"Oncotarget"},{"key":"B143","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3389\/fpls.2019.01173","article-title":"Bidirectional Promoter-Based CRISPR-Cas9 Systems for Plant Genome Editing","volume":"10","author":"Ren","year":"2019","journal-title":"Front. Plant Sci."},{"key":"B144","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1038\/s41388-021-01724-6","article-title":"In Vivo CRISPR Inactivation of Fos Promotes Prostate Cancer Progression by Altering the Associated AP-1 Subunit Jun","volume":"40","author":"Riedel","year":"2021","journal-title":"Oncogene"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.4172\/2161-0460.1000439","article-title":"The Potential of CRISPR\/Cas9 Gene Editing as a Treatment Strategy for Alzheimer's Disease","volume":"8","author":"Rohn","year":"2018","journal-title":"J. Alzheimer's Dis. Parkinsonism."},{"key":"B146","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-00462-8","article-title":"CRISPR\/Cas9-mediated PD-1 Disruption Enhances Anti-tumor Efficacy of Human Chimeric Antigen Receptor T Cells","volume":"7","author":"Rupp","year":"2017","journal-title":"Scientific Rep."},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202000770","article-title":"In Vivo CRISPR\/Cas9 Knockout Screen: TCEAL1 Silencing Enhances Docetaxel Efficacy in Prostate Cancer","volume":"3","author":"Rushworth","year":"2020","journal-title":"Life Sci. alliance"},{"key":"B148","doi-asserted-by":"publisher","first-page":"866","DOI":"10.3760\/cma.j.issn.1007-3418.2019.11.009","article-title":"Abnormal Expression of Wnt3a and Inhibiting Role of its Molecular-Targeted Intervening in Hepatocellular Carcinoma","volume":"27","author":"Sai","year":"2019","journal-title":"Zhonghua gan zang bing Za zhi= Zhonghua ganzangbing zazhi= Chin. J. Hepatol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"W599","DOI":"10.1093\/nar\/gkm349","article-title":"Zinc Finger Targeter (ZiFiT): an Engineered Zinc finger\/target Site Design Tool","volume":"35","author":"Sander","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"B150","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.stem.2013.11.002","article-title":"Functional Repair of CFTR by CRISPR\/Cas9 in Intestinal Stem Cell Organoids of Cystic Fibrosis Patients","volume":"13","author":"Schwank","year":"2013","journal-title":"Cell stem cell"},{"key":"B151","doi-asserted-by":"publisher","first-page":"4566","DOI":"10.1093\/hmg\/ddw286","article-title":"Permanent Inactivation of Huntington's Disease Mutation by Personalized Allele-specific CRISPR\/Cas9","volume":"25","author":"Shin","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"B152","doi-asserted-by":"publisher","first-page":"1756285617741837","DOI":"10.1177\/1756285617741837","article-title":"The Prospects of CRISPR-Based Genome Engineering in the Treatment of Neurodegenerative Disorders","volume":"11","author":"Shin","year":"2018","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"B153","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1089\/scd.2014.0347","article-title":"Improved Hematopoietic Differentiation Efficiency of Gene-Corrected Beta-Thalassemia Induced Pluripotent Stem Cells by CRISPR\/Cas9 System","volume":"24","author":"Song","year":"2015","journal-title":"Stem Cell Dev."},{"key":"B154","doi-asserted-by":"publisher","first-page":"e0202868","DOI":"10.1371\/journal.pone.0202868","article-title":"Efficient Genome Editing Using tRNA Promoter-Driven CRISPR\/Cas9 gRNA in Aspergillus niger","volume":"13","author":"Song","year":"2018","journal-title":"PloS one"},{"key":"B155","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1182\/blood.2020005185","article-title":"Endogenous TCR Promotes In Vivo Persistence of CD19-CAR-T Cells Compared to a CRISPR\/Cas9-mediated TCR Knockout CAR","volume":"136","author":"Stenger","year":"2020","journal-title":"Blood"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.3791\/59629","article-title":"Using CRISPR\/Cas9 to Knock Out GM-CSF in CAR-T Cells","author":"Sterner","year":"","journal-title":"J. visualized experiments: JoVE"},{"key":"B157","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1182\/blood-2018-10-881722","article-title":"GM-CSF Inhibition Reduces Cytokine Release Syndrome and Neuroinflammation but Enhances CAR-T Cell Function in Xenografts","volume":"133","author":"Sterner","year":"","journal-title":"Blood"},{"key":"B158","doi-asserted-by":"publisher","first-page":"e01307","DOI":"10.1128\/JCM.01307-18","article-title":"CRISPR-cas Biology and its Application to Infectious Diseases","volume":"57","author":"Strich","year":"2019","journal-title":"J. Clin. Microbiol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"dmm032201","DOI":"10.1242\/dmm.032201","article-title":"A Novel Rabbit Model of Duchenne Muscular Dystrophy Generated by CRISPR\/Cas9","volume":"11","author":"Sui","year":"2018","journal-title":"Dis. Model. Mech."},{"key":"B160","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep10342","article-title":"Targeted Mutagenesis in Soybean Using the CRISPR-Cas9 System","volume":"5","author":"Sun","year":"2015","journal-title":"Scientific Rep."},{"key":"B161","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1002\/jor.24227","article-title":"Targeting Mutant TP53 as a Potential Therapeutic Strategy for the Treatment of Osteosarcoma","volume":"37","author":"Tang","year":"2019","journal-title":"J. orthopaedic researchofficial Publ. Orthopaedic Res. Soc."},{"key":"B162","doi-asserted-by":"publisher","first-page":"e133977","DOI":"10.1172\/jci.insight.133977","article-title":"TGF-\u03b2 Inhibition via CRISPR Promotes the Long-Term Efficacy of CAR T Cells against Solid Tumors","volume":"5","author":"Tang","year":"2020","journal-title":"JCI insight"},{"key":"B163","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1056\/nejmoa040720","article-title":"Docetaxel Plus Prednisone or Mitoxantrone Plus Prednisone for Advanced Prostate Cancer","volume":"351","author":"Tannock","year":"2004","journal-title":"New Engl. J. Med."},{"key":"B164","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms11750","article-title":"Internal Guide RNA Interactions Interfere with Cas9-Mediated Cleavage","volume":"7","author":"Thyme","year":"2016","journal-title":"Nat. Commun."},{"key":"B165","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13058-017-0904-8","article-title":"FUT8 Promotes Breast Cancer Cell Invasiveness by Remodeling TGF-\u03b2 Receptor Core Fucosylation","volume":"19","author":"Tu","year":"2017","journal-title":"Breast Cancer Res."},{"key":"B166","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-015-0031-x","article-title":"CRISPR\/Cas9: a Powerful Genetic Engineering Tool for Establishing Large Animal Models of Neurodegenerative Diseases","volume":"10","author":"Tu","year":"2015","journal-title":"Mol. neurodegeneration"},{"key":"B167","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-12281-8","article-title":"Optimized CRISPR Guide RNA Design for Two High-Fidelity Cas9 Variants by Deep Learning","volume":"10","author":"Wang","year":"2019","journal-title":"Nat. Commun."},{"key":"B168","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s10529-020-03024-7","article-title":"CRISPR\/Cas9-mediated Genome Editing in Penicillium oxalicum and Trichoderma Reesei Using 5S rRNA Promoter-Driven Guide RNAs","volume":"43","author":"Wang","year":"2021","journal-title":"Biotechnol. Lett."},{"key":"B169","doi-asserted-by":"publisher","first-page":"11654","DOI":"10.1074\/jbc.ac118.004404","article-title":"No Off-Target Mutations in Functional Genome Regions of a CRISPR\/Cas9-generated Monkey Model of Muscular Dystrophy","volume":"293","author":"Wang","year":"2018","journal-title":"J. Biol. Chem."},{"key":"B170","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1186\/s12885-020-06899-x","article-title":"ALDH1A3 Serves as a Predictor for Castration Resistance in Prostate Cancer Patients","volume":"20","author":"Wang","year":"2020","journal-title":"BMC cancer"},{"key":"B171","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1126\/science.1246981","article-title":"Genetic Screens in Human Cells Using the CRISPR-Cas9 System","volume":"343","author":"Wang","year":"2014","journal-title":"Science (New York, NY)"},{"key":"B172","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1007\/s13238-017-0400-z","article-title":"Current Status and Perspectives of Chimeric Antigen Receptor Modified T Cells for Cancer Treatment","volume":"8","author":"Wang","year":"2017","journal-title":"Protein & cell"},{"key":"B173","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2147\/jep.s235233","article-title":"TGF-\u03b2-Induced TMEPAI Attenuates the Response of Triple-Negative Breast Cancer Cells to Doxorubicin and Paclitaxel","volume":"12","author":"Wardhani","year":"2020","journal-title":"J. Exp. Pharmacol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-018-0779-3","article-title":"One-step Genetic Correction of Hemoglobin E\/beta-thalassemia Patient-Derived iPSCs by the CRISPR\/Cas9 System","volume":"9","author":"Wattanapanitch","year":"2018","journal-title":"Stem Cel. Res. Ther."},{"key":"B175","doi-asserted-by":"publisher","first-page":"4681","DOI":"10.1038\/s41467-019-12606-7","article-title":"Genome-wide CRISPR\/Cas9 Library Screening Identified PHGDH as a Critical Driver for Sorafenib Resistance in HCC","volume":"10","author":"Wei","year":"2019","journal-title":"Nat. Commun."},{"key":"B176","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1261\/rna.057596.116","article-title":"CRISPR\/Cas9 with Single Guide RNA Expression Driven by Small tRNA Promoters Showed Reduced Editing Efficiency Compared to a U6 Promoter","volume":"23","author":"Wei","year":"2017","journal-title":"RNA"},{"key":"B177","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1146\/annurev.physiol.61.1.283","article-title":"Genetic Diseases and Gene Knockouts Reveal Diverse Connexin Functions","volume":"61","author":"White","year":"1999","journal-title":"Annu. Rev. Physiol."},{"key":"B178","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13059-015-0784-0","article-title":"Characteristics of Functional Guide RNAs for the CRISPR\/Cas9 System","volume":"16","author":"Wong","year":"2015","journal-title":"Genome Biol."},{"key":"B179","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-015-0784-0","article-title":"Characteristics of Functional Guide RNAs for the CRISPR\/Cas9 System","volume":"16","author":"Wong","year":"2015","journal-title":"Genome Biol."},{"key":"B180","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2174\/1566523217666171121165046","article-title":"Therapeutic Applications of CRISPR\/Cas for Duchenne Muscular Dystrophy","volume":"17","author":"Wong","year":"2017","journal-title":"Curr. Gene Ther."},{"key":"B181","doi-asserted-by":"publisher","first-page":"4374","DOI":"10.7150\/thno.43360","article-title":"Advances in CRISPR\/Cas-based Gene Therapy in Human Genetic Diseases","volume":"10","author":"Wu","year":"2020","journal-title":"Theranostics"},{"key":"B182","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s40484-014-0030-x","article-title":"Target Specificity of the CRISPR-Cas9 System","volume":"2","author":"Wu","year":"2014","journal-title":"Quant Biol."},{"key":"B183","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1159\/000495714","article-title":"Targeting CD44 by CRISPR-Cas9 in Multi-Drug Resistant Osteosarcoma Cells","volume":"51","author":"Xiao","year":"2018","journal-title":"Cell Physiol. Biochem. : Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"key":"B184","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/bfgp\/elw021","article-title":"Applications of the CRISPR\/Cas9 System in Murine Cancer Modeling","volume":"16","author":"Xiao-Jie","year":"2017","journal-title":"Brief. Funct. genomics"},{"key":"B185","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1101\/gr.173427.114","article-title":"Seamless Gene Correction of \u03b2-thalassemia Mutations in Patient-specific iPSCs Using CRISPR\/Cas9 and piggyBac","volume":"24","author":"Xie","year":"2014","journal-title":"Genome Res."},{"key":"B186","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1101\/gr.191452.115","article-title":"Sequence Determinants of Improved CRISPR sgRNA Design","volume":"25","author":"Xu","year":"2015","journal-title":"Genome Res."},{"key":"B187","doi-asserted-by":"publisher","first-page":"94166","DOI":"10.18632\/oncotarget.21607","article-title":"Optimized Guide RNA Structure for Genome Editing via Cas9","volume":"8","author":"Xu","year":"2017","journal-title":"Oncotarget"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.139813","article-title":"Phenotypes of CF Rabbits Generated by CRISPR\/Cas9-mediated Disruption of the CFTR Gene","volume":"6","author":"Xu","year":"2021","journal-title":"JCI insight"},{"key":"B189","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep12065","article-title":"Both TALENs and CRISPR\/Cas9 Directly Target the HBB IVS2\u2013654 (C> T) Mutation in \u03b2-thalassemia-derived iPSCs","volume":"5","author":"Xu","year":"2015","journal-title":"Scientific Rep."},{"key":"B190","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3760\/cma.j.issn.1003-9406.2018.02.003","article-title":"Knocking-out of HIF1\u03b1 Gene by CRISPR\/cas9 Inhibits Proliferation and Invasiveness of Prostate Cancer DU145 Cells","volume":"35","author":"Xu","year":"2018","journal-title":"Zhonghua Yi Xue Yi chuan Xue Za Zhi = Zhonghua yixue yichuanxue zazhi = Chin. J. Med. Genet."},{"key":"B191","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.cell.2016.04.003","article-title":"Crystal Structure of Cpf1 in Complex with Guide RNA and Target DNA","volume":"165","author":"Yamano","year":"2016","journal-title":"Cell"},{"key":"B192","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.cell.2018.03.005","article-title":"A Huntingtin Knockin Pig Model Recapitulates Features of Selective Neurodegeneration in Huntington's Disease","volume":"173","author":"Yan","year":"2018","journal-title":"Cell"},{"key":"B193","doi-asserted-by":"publisher","first-page":"3849","DOI":"10.2147\/ott.s195661","article-title":"Impact of CXCR4 and CXCR7 Knockout by CRISPR\/Cas9 on the Function of Triple-Negative Breast Cancer Cells","volume":"12","author":"Yang","year":"2019","journal-title":"OncoTargets Ther."},{"key":"B194","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1172\/jci92087","article-title":"CRISPR\/Cas9-mediated Gene Editing Ameliorates Neurotoxicity in Mouse Model of Huntington's Disease","volume":"127","author":"Yang","year":"2017","journal-title":"J. Clin. Invest."},{"key":"B195","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fnmol.2016.00030","article-title":"CRISPR\/Cas9: Implications for Modeling and Therapy of Neurodegenerative Diseases","volume":"9","author":"Yang","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"B196","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/cr.2017.76","article-title":"Homology-mediated End Joining-Based Targeted Integration Using CRISPR\/Cas9","volume":"27","author":"Yao","year":"2017","journal-title":"Cell Res."},{"key":"B197","doi-asserted-by":"publisher","first-page":"10661","DOI":"10.1073\/pnas.1612075113","article-title":"Genome Editing Using CRISPR-Cas9 to Create the HPFH Genotype in HSPCs: An Approach for Treating Sickle Cell Disease and \u03b2-thalassemia","volume":"113","author":"Ye","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B198","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12943-019-0941-2","article-title":"N-myc Promotes Therapeutic Resistance Development of Neuroendocrine Prostate Cancer by Differentially Regulating miR-421\/ATM Pathway","volume":"18","author":"Yin","year":"2019","journal-title":"Mol. Cancer"},{"key":"B199","doi-asserted-by":"publisher","first-page":"6729","DOI":"10.1038\/s41598-019-43141-6","article-title":"CRISPR-Cas9 Editing in Maize: Systematic Evaluation of Off-Target Activity and its Relevance in Crop Improvement","volume":"9","author":"Young","year":"2019","journal-title":"Scientific Rep."},{"key":"B200","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.3390\/ijms17101668","article-title":"Porcine Zygote Injection with Cas9\/sgRNA Results in DMD-Modified Pig with Muscle Dystrophy","volume":"17","author":"Yu","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"B201","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.2147\/cmar.s202799","article-title":"Apolipoprotein M Could Inhibit Growth and Metastasis of SMMC7721 Cells via Vitamin D Receptor Signaling","volume":"11","author":"Yu","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"B202","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.2147\/cmar.s202799","article-title":"Apolipoprotein M Could Inhibit Growth and Metastasis of SMMC7721 Cells via Vitamin D Receptor Signaling","volume":"11","author":"Yu","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"B203","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40364-017-0081-z","article-title":"Engineering Car-T Cells","volume":"5","author":"Zhang","year":"2017","journal-title":"Biomark Res."},{"key":"B204","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1007\/s00299-017-2202-4","article-title":"Rapid and Efficient CRISPR\/Cas9 Gene Editing in Citrus Using the YAO Promoter","volume":"36","author":"Zhang","year":"2017","journal-title":"Plant Cel. Rep."},{"key":"B205","doi-asserted-by":"publisher","first-page":"R40","DOI":"10.1093\/hmg\/ddu125","article-title":"CRISPR\/Cas9 for Genome Editing: Progress, Implications and Challenges","volume":"23","author":"Zhang","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"B206","doi-asserted-by":"publisher","first-page":"28566","DOI":"10.1038\/srep28566","article-title":"Different Effects of sgRNA Length on CRISPR-Mediated Gene Knockout Efficiency","volume":"6","author":"Zhang","year":"2016","journal-title":"Scientific Rep."},{"key":"B207","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.3389\/fimmu.2020.01871","article-title":"Consequences of CRISPR-Cas9-Mediated CFTR Knockout in Human Macrophages","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Immunol."},{"key":"B208","doi-asserted-by":"publisher","first-page":"e264","DOI":"10.1038\/mtna.2015.37","article-title":"Off-target Effects in CRISPR\/Cas9-mediated Genome Engineering","volume":"4","author":"Zhang","year":"2015","journal-title":"Mol. Therapy-Nucleic Acids"},{"key":"B209","doi-asserted-by":"publisher","first-page":"eaay6812","DOI":"10.1126\/sciadv.aay6812","article-title":"Enhanced CRISPR-Cas9 Correction of Duchenne Muscular Dystrophy in Mice by a Self-Complementary AAV Delivery System","volume":"6","author":"Zhang","year":"2020","journal-title":"Sci. Adv."},{"key":"B210","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1007\/s11684-017-0543-6","article-title":"CRISPR-Cas9 Mediated LAG-3 Disruption in CAR-T Cells","volume":"11","author":"Zhang","year":"2017","journal-title":"Front. Med."},{"key":"B211","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.7150\/ijbs.37152","article-title":"Evaluation of the Effects of Sequence Length and Microsatellite Instability on Single-Guide RNA Activity and Specificity","volume":"15","author":"Zhao","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"B212","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-018-0677-2","article-title":"Universal CARs, Universal T Cells, and Universal CAR T Cells","volume":"11","author":"Zhao","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"B213","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1021\/acssynbio.7b00456","article-title":"5S rRNA Promoter for Guide RNA Expression Enabled Highly Efficient CRISPR\/Cas9 Genome Editing in Aspergillus niger","volume":"8","author":"Zheng","year":"2018","journal-title":"ACS Synth. Biol."},{"key":"B214","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1007\/s00432-020-03207-9","article-title":"Genome-wide CRISPR Knockout Screens Identify ADAMTSL3 and PTEN Genes as Suppressors of HCC Proliferation and Metastasis, Respectively","volume":"146","author":"Zhou","year":"2020","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"B215","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1038\/s41388-018-0180-9","article-title":"KPNB1 Inhibition Disrupts Proteostasis and Triggers Unfolded Protein Response-Mediated Apoptosis in Glioblastoma Cells","volume":"37","author":"Zhu","year":"2018","journal-title":"Oncogene"}],"updated-by":[{"DOI":"10.3389\/fbioe.2023.1285036","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"record-id":"47342"},{"DOI":"10.3389\/fbioe.2023.1285036","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000}}],"container-title":["Frontiers in Bioengineering and Biotechnology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2021.775309\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T12:18:46Z","timestamp":1713183526000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2021.775309\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,19]]},"references-count":215,"alternative-id":["10.3389\/fbioe.2021.775309"],"URL":"https:\/\/doi.org\/10.3389\/fbioe.2021.775309","relation":{"retraction":[{"id-type":"doi","id":"10.3389\/fbioe.2023.1285036","asserted-by":"object"}]},"ISSN":["2296-4185"],"issn-type":[{"value":"2296-4185","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,19]]},"article-number":"775309"}}